PL396696A1 - Preparat farmaceutyczny i/lub kosmetyczny - Google Patents
Preparat farmaceutyczny i/lub kosmetycznyInfo
- Publication number
- PL396696A1 PL396696A1 PL396696A PL39669600A PL396696A1 PL 396696 A1 PL396696 A1 PL 396696A1 PL 396696 A PL396696 A PL 396696A PL 39669600 A PL39669600 A PL 39669600A PL 396696 A1 PL396696 A1 PL 396696A1
- Authority
- PL
- Poland
- Prior art keywords
- alkyl
- pharmaceutical
- cosmetic preparation
- formula
- disclosed
- Prior art date
Links
- 239000002537 cosmetic Substances 0.000 title 1
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 208000017520 skin disease Diseases 0.000 abstract 2
- 201000004384 Alopecia Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010042496 Sunburn Diseases 0.000 abstract 1
- 206010053615 Thermal burn Diseases 0.000 abstract 1
- 208000024963 hair loss Diseases 0.000 abstract 1
- 230000003676 hair loss Effects 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- CBOIHMRHGLHBPB-UHFFFAOYSA-N hydroxymethyl Chemical compound O[CH2] CBOIHMRHGLHBPB-UHFFFAOYSA-N 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL396696A PL396696A1 (pl) | 1999-01-07 | 2000-01-07 | Preparat farmaceutyczny i/lub kosmetyczny |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL330768A PL190755B1 (pl) | 1999-01-07 | 1999-01-07 | Preparat do leczenia i profilaktyki chorób skóry |
| PL396696A PL396696A1 (pl) | 1999-01-07 | 2000-01-07 | Preparat farmaceutyczny i/lub kosmetyczny |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL396696A1 true PL396696A1 (pl) | 2012-01-16 |
Family
ID=20073560
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL330768A PL190755B1 (pl) | 1999-01-07 | 1999-01-07 | Preparat do leczenia i profilaktyki chorób skóry |
| PL396696A PL396696A1 (pl) | 1999-01-07 | 2000-01-07 | Preparat farmaceutyczny i/lub kosmetyczny |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL330768A PL190755B1 (pl) | 1999-01-07 | 1999-01-07 | Preparat do leczenia i profilaktyki chorób skóry |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1147086B9 (pl) |
| AT (1) | ATE292117T1 (pl) |
| AU (1) | AU1792700A (pl) |
| CZ (1) | CZ299662B6 (pl) |
| DE (1) | DE60019086T2 (pl) |
| ES (1) | ES2238985T3 (pl) |
| HU (1) | HU225475B1 (pl) |
| PL (2) | PL190755B1 (pl) |
| RU (1) | RU2199319C1 (pl) |
| SK (1) | SK285869B6 (pl) |
| UA (1) | UA73491C2 (pl) |
| WO (1) | WO2000040559A1 (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ303214B6 (cs) * | 2001-03-21 | 2012-05-30 | Torrent Pharmaceuticals Ltd | Pyridiniová sloucenina, zpusob její výroby, její použití, farmaceutický prostredek ji obsahující, zpusob jeho výroby a jeho použití |
| SE0102380D0 (sv) * | 2001-07-02 | 2001-07-02 | Macronova Ab | Kräm för behandling av åldersförändringar i huden hos människa |
| RU2336867C2 (ru) * | 2003-05-30 | 2008-10-27 | ПАОЛИ АМБРОЗИ Джанфранко ДЕ | Композиция для дермального применения, обладающая фотозащитным и антиэритемным действием, содержащая солнечный фильтр и диметилсульфон |
| RU2266538C2 (ru) * | 2003-08-27 | 2005-12-20 | Ванчакова Нина Павловна | Способ идентификации противозудного эффекта антидепрессанта |
| PL364348A1 (pl) | 2004-01-12 | 2005-07-25 | PHARMENA Sp.z o.o. | Zastosowanie czwartorzędowych soli pirydyniowych jako środka naczynioprotekcyjnego |
| DE102004013798A1 (de) * | 2004-03-20 | 2005-10-06 | Wella Aktiengesellschaft | Verwendung von Mitteln zur kosmetischen Behandlung von Keratin enthaltenden Material |
| WO2007074406A2 (en) | 2005-07-11 | 2007-07-05 | Pharmena North America Inc. | Formulations for treatment of lipoprotein abnormalities comprising a statin a statin and a methylnicotinamide derivative |
| ATE438625T1 (de) * | 2005-12-09 | 2009-08-15 | Cerecon Ag | Quaternäre 3-amido, n-methylpyridiniumsalze als entzündungshemmende mittel |
| DK2026651T3 (da) * | 2006-03-08 | 2013-07-08 | Cortria Corp | Kombinationsterapi med ikke-selektive COX-inhibitorer til forebyggelse af COX-relaterede maveskader |
| US20080112968A1 (en) * | 2006-10-11 | 2008-05-15 | Dermena | Nicotinamide compositions for treatment of skin diseases and disorders |
| CA2700585A1 (en) * | 2006-10-18 | 2008-08-14 | Dermena North America, Inc. | Food extracts for treatment of lipoprotein abnormalities and skin diseases and skin disorders |
| US20100240621A1 (en) * | 2007-09-10 | 2010-09-23 | Glenmark Pharmaceuticals Ltd. | Topical pharmaceutical composition for the combination of fusidic acid and a corticosteroid |
| PL2211858T3 (pl) | 2007-10-12 | 2015-06-30 | Politechnika Lodzka | Zastosowanie czwartorzędowych soli pirydyniowych do hamowania przerzutów nowotworowych |
| TWI432188B (zh) * | 2008-12-19 | 2014-04-01 | Merz Pharma Gmbh & Co Kgaa | 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類 |
| WO2018015862A1 (en) | 2016-07-18 | 2018-01-25 | Pharmena S.A. | 1-methylnicotinamide salts for use in raising the blood levels of adiponectin |
| JP7608422B2 (ja) | 2019-07-12 | 2025-01-06 | ユニリーバー・アイピー・ホールディングス・ベスローテン・ヴェンノーツハップ | 生体エネルギー組み合わせ及びそれの使用方法 |
| WO2021205341A1 (en) | 2020-04-07 | 2021-10-14 | Pharmena S.A. | 1-methylnicotinamide for the prevention/treatment of inflammatory airway diseases |
| PL246761B1 (pl) * | 2023-05-10 | 2025-03-03 | Politechnika Poznanska | Sposób otrzymywania czwartorzędowych soli amoniowych z kationem 3-karbamoilo-1-alkilopirydyniowym i anionem salicylanowym |
| PL248942B1 (pl) * | 2024-01-31 | 2026-02-16 | Politechnika Poznanska | Czwartorzędowe sole amoniowe zawierające anion 2-furanokarboksylanowy i kation będący alkilową pochodną nikotynamidu, sposób ich otrzymywania i zastosowanie jako środki myjąco-dezynfekujące |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3823076A (en) * | 1972-05-23 | 1974-07-09 | Du Pont | Zinc electroplating additive |
| US4067975A (en) * | 1975-08-04 | 1978-01-10 | Yu Ruey J | Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide |
| US4505896A (en) * | 1979-04-19 | 1985-03-19 | Elorac, Ltd. | Method of treating acne vulgaris and composition |
| US4578394A (en) * | 1984-12-10 | 1986-03-25 | Hoechst-Roussel Pharmaceuticals Incorporated | Cholinergic function increasing 3-[N-(pyridyl) carbamoyl]-1,4-dihydropyridines |
| DE3603601C3 (de) * | 1986-02-06 | 1999-12-23 | Jutta Mai | Verwendung eines Bockshornkleesamenextraktes |
| US4786647A (en) * | 1986-06-30 | 1988-11-22 | University Of Florida | Method for eliciting anxiolysis |
| ZA892928B (en) * | 1988-04-25 | 1991-01-30 | Pro Neuron Inc | Pharmaceutical compositions containing deoxyribonucleosides for wound healing |
| US5372911A (en) * | 1991-06-13 | 1994-12-13 | Dainippon Ink And Chemicals, Inc. | Process of forming super high-contrast negative images and silver halide photographic material and developer being used therefor |
| US6238678B1 (en) * | 1995-11-06 | 2001-05-29 | The Procter & Gamble Company | Methods of regulating skin appearance with vitamin B3 compound |
| RU2085187C1 (ru) * | 1995-11-22 | 1997-07-27 | Исследовательская корпорация МДТ | Гель для ухода за кожей и лечения ее заболеваний и композиция для его получения |
| US6028111A (en) * | 1996-03-08 | 2000-02-22 | Oxigene, Inc. | Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| US20040102358A1 (en) * | 1997-05-19 | 2004-05-27 | Scivoletto Rosemarie | Composition for treating skin conditions |
| EP1063994A1 (en) * | 1998-03-16 | 2001-01-03 | The Procter & Gamble Company | Method of treating skin irritation |
-
1999
- 1999-01-07 PL PL330768A patent/PL190755B1/pl unknown
-
2000
- 2000-01-07 HU HU0104963A patent/HU225475B1/hu unknown
- 2000-01-07 RU RU2001121650/14A patent/RU2199319C1/ru active
- 2000-01-07 ES ES00900030T patent/ES2238985T3/es not_active Expired - Lifetime
- 2000-01-07 DE DE60019086T patent/DE60019086T2/de not_active Expired - Lifetime
- 2000-01-07 WO PCT/IB2000/000019 patent/WO2000040559A1/en not_active Ceased
- 2000-01-07 EP EP00900030A patent/EP1147086B9/en not_active Expired - Lifetime
- 2000-01-07 AU AU17927/00A patent/AU1792700A/en not_active Abandoned
- 2000-01-07 CZ CZ20012450A patent/CZ299662B6/cs not_active IP Right Cessation
- 2000-01-07 AT AT00900030T patent/ATE292117T1/de active
- 2000-01-07 PL PL396696A patent/PL396696A1/pl unknown
- 2000-01-07 SK SK951-2001A patent/SK285869B6/sk not_active IP Right Cessation
- 2000-07-01 UA UA2001075379A patent/UA73491C2/uk unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2238985T3 (es) | 2005-09-16 |
| DE60019086D1 (de) | 2005-05-04 |
| SK9512001A3 (en) | 2001-12-03 |
| RU2001121650A (ru) | 2004-02-27 |
| UA73491C2 (uk) | 2005-08-15 |
| SK285869B6 (sk) | 2007-10-04 |
| RU2199319C1 (ru) | 2003-02-27 |
| HUP0104963A3 (en) | 2002-11-28 |
| HU225475B1 (en) | 2006-12-28 |
| EP1147086A1 (en) | 2001-10-24 |
| PL190755B1 (pl) | 2006-01-31 |
| PL330768A1 (en) | 2000-07-17 |
| DE60019086T2 (de) | 2006-02-02 |
| CZ299662B6 (cs) | 2008-10-08 |
| WO2000040559A1 (en) | 2000-07-13 |
| CZ20012450A3 (cs) | 2002-10-16 |
| EP1147086B1 (en) | 2005-03-30 |
| ES2238985T9 (es) | 2011-03-24 |
| HUP0104963A2 (hu) | 2002-04-29 |
| EP1147086B9 (en) | 2010-09-22 |
| AU1792700A (en) | 2000-07-24 |
| ATE292117T1 (de) | 2005-04-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1792700A (en) | Compositions for the treatment of skin diseases | |
| SE9604786D0 (sv) | New compounds | |
| CA2332389A1 (en) | Liposomal preparations for the application of antiseptic agents to the interior of the body | |
| GB2284351B (en) | Terfenadine metabolites and their optically pure isomers for treating allergic disorders | |
| TR200001840T2 (tr) | Arile bağlı azopolisiklik bileşikler | |
| AU2001270554A1 (en) | Use of an (r)-enantiomer of lipoic acid in cosmetics and dermatologicals | |
| CA2259621A1 (en) | Isocoumarin derivatives and their use in medicines | |
| AU2003263878A1 (en) | Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents | |
| CA2396186A1 (en) | Agents for the treatment of skin disorders | |
| ITMI950575A0 (it) | Preparati igienici e cosmetici per prevenire e trattare malattie della pelle nonche' procedimento per il loro ottenimento | |
| BG106155A (en) | Novel derivatives and analogues of galanthamin | |
| AU2108500A (en) | Galenic formulation containing biotin | |
| KR960000855A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제조성물 | |
| IL122196A0 (en) | Bicyclic-aromatic compounds | |
| KR960010002A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
| ES2194055T3 (es) | Nuevo uso de prostaglandinas. | |
| GEP20043202B (en) | Resorcinol Derivatives | |
| AU2003296692A1 (en) | Lipidic protein-transfer systems and cosmetic/dermatological use thereof | |
| CA2417935A1 (en) | Anti-inflammatory medicament | |
| CA2340734A1 (en) | Optically active pyridyl-4h-1,2,4-oxadiazine derivative and its use in the treatment of vascular diseases | |
| KR960010003A (ko) | L-카르니틴염과 이를 함유한 피부질환 치료용 화장품 조성물 및 약제 조성물 | |
| AU2173101A (en) | Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride as anti-inflammatory agents | |
| GEP20043231B (en) | Resorcinol Composition | |
| TR199900013T2 (xx) | Yeni bile�ikler. | |
| US6288112B1 (en) | Use of pyrethroid compounds to promote hair growth |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |